BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24751348)

  • 1. PCR for detection of oseltamivir resistance mutation in influenza A(H7N9) virus.
    Wang W; Song Z; Guan W; Liu Y; Zhang X; Xu L; Li J; Yuan Z; Hu Y
    Emerg Infect Dis; 2014 May; 20(5):847-9. PubMed ID: 24751348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population.
    Yen HL; McKimm-Breschkin JL; Choy KT; Wong DD; Cheung PP; Zhou J; Ng IH; Zhu H; Webby RJ; Guan Y; Webster RG; Peiris JS
    mBio; 2013 Jul; 4(4):. PubMed ID: 23860768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.
    Marjuki H; Mishin VP; Chesnokov AP; De La Cruz JA; Davis CT; Villanueva JM; Fry AM; Gubareva LV
    J Virol; 2015 May; 89(10):5419-26. PubMed ID: 25740997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution of I222L-E119V in neuraminidase from highly pathogenic avian influenza H7N9 virus exhibited synergistic resistance effect to oseltamivir in mice.
    Tang J; Gao R; Liu L; Zhang S; Liu J; Li X; Fang Q; Feng Z; Xu C; Huang W; Wang D
    Sci Rep; 2021 Aug; 11(1):16293. PubMed ID: 34381119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel pyrosequencing assay for the detection of neuraminidase inhibitor resistance-conferring mutations among clinical isolates of avian H7N9 influenza virus.
    Qi Y; Fan H; Qi X; Zhu Z; Guo X; Chen Y; Ge Y; Zhao K; Wu T; Li Y; Shan Y; Zhou M; Shi Z; Wang H; Cui L
    Virus Res; 2014 Jan; 179():119-24. PubMed ID: 24211668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug susceptibility of wild-type and mutant H7N9 neuraminidase to zanamivir and oseltamivir].
    Wei YN; Zhang C; Chen Q; Guo Y
    Bing Du Xue Bao; 2014 Jul; 30(4):396-401. PubMed ID: 25272593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.
    Marjuki H; Mishin VP; Chesnokov AP; Jones J; De La Cruz JA; Sleeman K; Tamura D; Nguyen HT; Wu HS; Chang FY; Liu MT; Fry AM; Cox NJ; Villanueva JM; Davis CT; Gubareva LV
    J Infect Dis; 2015 Jan; 211(2):249-57. PubMed ID: 25124927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R292K substitution and drug susceptibility of influenza A(H7N9) viruses.
    Sleeman K; Guo Z; Barnes J; Shaw M; Stevens J; Gubareva LV
    Emerg Infect Dis; 2013; 19(9):1521-4. PubMed ID: 23965618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian influenza H7N9 virus from human cases in Mainland of China, 2016-2019.
    Tang J; Zhang SX; Zhang J; Li XY; Zhou JF; Zou SM; Bo H; Xin L; Yang L; Liu J; Huang WJ; Dong J; Wang DY
    Virology; 2020 Oct; 549():77-84. PubMed ID: 32853849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrosequencing reveals an oseltamivir-resistant marker in the quasispecies of avian influenza A (H7N9) virus.
    Mok CK; Chang SC; Chen GW; Lo YL; Chen SJ; Wu HS; Liu MT; Chang FY; Lin TY; Shih SR
    J Microbiol Immunol Infect; 2015 Aug; 48(4):465-9. PubMed ID: 24388586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment.
    Liu Q; Ma J; Strayer DR; Mitchell WM; Carter WA; Ma W; Richt JA
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):165-9. PubMed ID: 24350808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility.
    Hai R; Schmolke M; Leyva-Grado VH; Thangavel RR; Margine I; Jaffe EL; Krammer F; Solórzano A; García-Sastre A; Palese P; Bouvier NM
    Nat Commun; 2013; 4():2854. PubMed ID: 24326875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.
    Gubareva LV; Sleeman K; Guo Z; Yang H; Hodges E; Davis CT; Baranovich T; Stevens J
    J Infect Dis; 2017 Sep; 216(suppl_4):S566-S574. PubMed ID: 28934455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of viral genomic mutations in novel influenza A (H7N9)-infected patients: the association between oseltamivir-resistant variants and viral shedding duration.
    Chen R; Zou Q; Xie G; Yu F; Yang X; Cao L; Huo Z; Zheng S
    Virus Genes; 2019 Oct; 55(5):592-599. PubMed ID: 31302878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts.
    Tang J; Zhang J; Zhou J; Zhu W; Yang L; Zou S; Wei H; Xin L; Huang W; Li X; Cheng Y; Wang D
    Virol J; 2019 Jul; 16(1):87. PubMed ID: 31266524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a quadruple qRT-PCR assay for simultaneous identification of highly and low pathogenic H7N9 avian influenza viruses and characterization against oseltamivir resistance.
    Yang Y; Li S; Wong G; Ma S; Xu Z; Zhao X; Li H; Xu W; Zheng H; Lin J; Zhao Q; Liu W; Liu Y; Gao GF; Bi Y
    BMC Infect Dis; 2018 Aug; 18(1):406. PubMed ID: 30111290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity.
    Woods CJ; Malaisree M; Long B; McIntosh-Smith S; Mulholland AJ
    Sci Rep; 2013 Dec; 3():3561. PubMed ID: 24356381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of substitutions in the neuraminidase of A(H7N9) influenza viruses selected following serial passage in the presence of different neuraminidase inhibitors.
    Farrukee R; Butler J; Reading PC; Hurt AC
    Antiviral Res; 2019 Aug; 168():68-75. PubMed ID: 31132385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution and characterization of influenza A(H7N9) virus under the selective pressure of peramivir.
    Ge Y; Chi Y; Min X; Zhao K; Wu B; Wu T; Zhu X; Shi Z; Zhu F; Cui L
    Virology; 2019 Oct; 536():58-67. PubMed ID: 31400550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid discrimination of oseltamivir-resistant 275Y and -susceptible 275H substitutions in the neuraminidase gene of pandemic influenza A/H1N1 2009 virus by duplex one-step RT-PCR assay.
    Nakauchi M; Ujike M; Obuchi M; Takashita E; Takayama I; Ejima M; Oba K; Konomi N; Odagiri T; Tashiro M; Kageyama T;
    J Med Virol; 2011 Jul; 83(7):1121-7. PubMed ID: 21567417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.